Interventional Cardiology & Surgery
From the Journals
Rheumatoid arthritis may raise risk for aortic stenosis
Data from a large cohort study also showed an increase in risk for aortic stenosis–related interventions and death.
Feature
PAD procedure overuse: A field in peril or ‘a few bad apples’?
Many patients, apparently, were not encouraged to make lifestyle changes, nor did they receive medication. Instead, they were advised from the get...
Latest News
Class I recall of all Impella left-sided heart pumps
The company will update the pump’s instructions for use to include guidance to clinicians on how to manage use of Impella in patients with TAVR....
From the Journals
Statins post PCI: Moderate intensity plus ezetimibe may be preferable
“If given the choice, if you can get the benefits from a cardiovascular perspective with a lower risk of diabetes, it makes sense to use the...
Latest News
Class I recall of Abbott Amplatzer delivery sheath
Because of the potential for serious injury or death, the agency has identified this as a class I recall.
From the Journals
Same-session PCI rates ‘surprisingly high’
In a large database, more than three-quarters of stable patients had percutaneous coronary intervention with the index catheterization,...
From the Journals
Invasive test may cut health care costs related to angina without obstructive CAD
“The concept is good; the only challenge is that this is a complicated set of manipulations in the cath lab to get to the results.”
From the Journals
Aspirin not the best antiplatelet for CAD secondary prevention in meta-analysis
“Taken together, our data challenge the central role of aspirin in secondary prevention and support a paradigm shift toward P2Y12 inhibitor...
Latest News
Expanded coverage of carotid stenting in CMS draft proposal
The decision proposal would expand coverage for CAS “to standard surgical risk patients by removing the limitation of coverage to only high...
From the Journals
Mixed bag: New performance data on femoral-popliteal artery revascularization
“This and other studies highlight the need to be cautious about offering PVI to patients with intermittent claudication.”
News from the FDA/CDC
FDA: No excess mortality risk from paclitaxel stents, balloons for peripheral intervention
“The updated RCT meta-analysis does not indicate that the use of paclitaxel-coated devices is associated with a late mortality risk.”